protruding-type lesions in the upper digestive tract (esophagus, stomach, duodenum) and lower digestive tract (colorectal). In addition to digestive tract-lifting new organisms, this product does not
Conditions
Interventions
Gold Standard:Physician's diagnosis
Index test:the 
diagnostic 
system 
for 
endoscopy
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Voluntarily participate in the trial and sign the informed consent form; 2. Aged 18 to 80 years old male and female; 3. Patients have indications for digestive endoscopy; 4. Patients are able to communicate well with the researcher and comply with the entire test requirements.
Exclusion criteria
Exclusion criteria: 1) Patients have contraindications for digestive endoscopy; 2) Those with high risk of complications such as digestive endoscopy, such as unstable heart and lung function, active bleeding, obstruction and suspected gastrointestinal perforation; 3) Patients with severe mental disorders 4) lactating, pregnant women; 5) Poor compliance, unwillingness or inability to follow the test plan requirements; 6) Other investigators believe that it is not suitable for participation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target lesion detection rate: In the clinical endoscopic operation of detecting protruding-type lesions, the difference in the detection speed of the endoscopic physician and the digestive endoscopic real-time auxiliary diagnosis system was compared.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Target lesion detection rate: In the clinical endoscopic operation of detecting protruding-type lesions, whether the digestive endoscopic physician found the lesion as a standard control, and determine the detection rate of the elevated neoplasm by the real-time auxiliary diagnostic system of digestive endoscopy SEN, SPE; | — |
Countries
China
Contacts
Public ContactTang Chengwei
Outcome results
None listed